Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
02/2006
02/22/2006CN1736451A Externally applied plaster for stopping muscles and bones pain
02/22/2006CN1736448A Medicinal preparation for treating cold abscess and all kinds of body surface ulcer
02/22/2006CN1736427A Ointment for treating traumatic injury and its preparation method
02/22/2006CN1736421A Main ingredient of anemone rhizome, preparation process and application thereof
02/22/2006CN1736420A Anti-inflammation capsule and preparation process thereof
02/22/2006CN1736419A Prescription of wine for treating arthritis and bony spur and manufacturing method thereof
02/22/2006CN1736415A Effervescence tablet of 'Shuang Huanglian' and its preparation process thereof
02/22/2006CN1736407A Wind arthralgia treating wine and manufacturing method thereof
02/22/2006CN1736405A Medicinal liquor for treating rheumatism
02/22/2006CN1736389A Application of sodium selenite in preparation of medicine for treating wind, dampness and cold caused arthralgia
02/22/2006CN1736376A Modulation of peroxisome proliferator-activated receptors
02/22/2006CN1736374A Application of (R)- flurbiprofenester in pharmacy, injection thereof and method for preparing the same
02/22/2006CN1736368A Paeonol soft capsule, its preparing process and application
02/22/2006CN1243093C Using phenylethyl caffeiate derivative, capsaicin and resin toxin to inhibit NF-KB
02/22/2006CN1243018C Blood vessel generating inhibitor
02/22/2006CN1243012C Sekolamin saponin compound
02/22/2006CN1243000C Tocopherols, tocotrienols, other chroman and side chain dervative and uses thereof
02/22/2006CN1242999C Benzo-isoselenazole derivatives and its use
02/22/2006CN1242992C Cyclic diamine compounds bearing six-membered cyclic groups
02/22/2006CN1242991C Aporphine esters and their use in therapy
02/22/2006CN1242989C Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-ichibiting anti-inflammatory and immune-suppressive agents
02/22/2006CN1242804C External used medicine for traumatic injury and preparation thereof
02/22/2006CN1242793C Prescription of traditional Chinese medicine for treating gynaecological disease, and preparation method
02/22/2006CN1242777C Muscle and bone pain plaster and its making method
02/22/2006CN1242764C Traditional Chinese medicine for treating spondylitis
02/22/2006CN1242761C Numbness-activating blood-circulation-promoting pain-relieving ointment
02/22/2006CN1242754C Chinese traditional medicine for upper respiratory tract infection
02/21/2006US7002036 For production of (poly)peptides; comprises Michael-type addition of nucleophile to a dialkyl 2-methylidenylpropan-1,3-dioate and conversion of ester to amino moiety
02/21/2006US7002012 Therapeutic treatment of septic shock; chemical condensation reaction by cyclization, amidation, chemical intermediates
02/21/2006US7002009 2-(1-isopropoxycarbonyloxy-2-methylpropyl)-7,8-dimethoxy-4(5H),10-dioxo-2H-1,2,3-triazolo[4,5-c][1]benzazepine; diffraction peaks at diffraction angles in a powder X-ray diffraction pattern; pure, stable crystal
02/21/2006US7001917 2-(4-(4-(4-Fluorophenyl)-3,5-imethyl-1H-pyrazol-1-yl)phenyl) ethyl (4-methylphenyl)sulfonylcarbamate ammonium salt, e.g., as an antagonist for Prostoglandin E receptor; analgesics; antipyretics; antiinflammatory agents
02/21/2006US7001914 Compounds
02/21/2006US7001899 7-member ring N-heterocycles that have a cysteine trap substitution; treating osteoarthritis
02/21/2006US7001599 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects
02/21/2006US7001595 For therapy of rheumatoid arthritis, inflammation, respiratory diseases, allergy
02/21/2006CA2395196C Cyclic amp-specific phosphodiesterase inhibitors
02/21/2006CA2283399C Pyridazinones as inhibitors of cyclooxygenase-2
02/21/2006CA2259997C Remedies and preventives for stomatitis
02/20/2006CA2478458A1 Treatment of pediatric multiple sclerosis
02/17/2006CA2478137A1 Metal ion chelate complexes and use thereof
02/16/2006WO2006017614A1 Use of n-desmethylclozapine to treat human neuropsychiatric disease
02/16/2006WO2006017406A1 Cyanoamidine p2x7 antagonists for the treatment of pain
02/16/2006WO2006016681A2 Crp lowering agent
02/16/2006WO2006016152A1 Anti-inflammatory agents
02/16/2006WO2006015930A1 Phenol derivatives
02/16/2006WO2006015870A1 Tetrahydro-naphthalene derivatives as glucocorticoid receptor modulators
02/16/2006WO2006015860A2 Pyrazole derivatives for treating conditions mediated by activation of the adenosine a2b or a3 receptor
02/16/2006WO2006015590A2 Novel formulation for l-tryptophane comprising carbidopa/benserazide
02/16/2006WO2005002525A3 Cox-2 and faah inhibitors
02/16/2006WO2003033720A8 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
02/16/2006WO2003025129A3 Neurotransmission-associated proteins
02/16/2006US20060036074 Bromodomain protein
02/16/2006US20060035979 Inhibitors of transcription factor NF-kappaB
02/16/2006US20060035977 Uses of acylated aminopropanediols and sulphur and nitrogen analogues of same f
02/16/2006US20060035959 e.g. (dibenzofuran-4-yl)-(3,5-dichlorophenylamino)acetic acid; glycine B antagonist on the NMDA receptor complex for regulating the calcium balance; analgesic,antiinflammatory, antidepressant, anxiolytic agent, neurodegenerative diseases; chronic and neuropathic pain
02/16/2006US20060035938 2-Pyridone derivatives as inhibitors of neutrophile elastase
02/16/2006US20060035925 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
02/16/2006US20060035916 2,4-Pyrimidinediamine compounds and their uses
02/16/2006US20060035878 Novel use of ansamycin antibiotics and method of screening novel angiogenesis inhibitor
02/16/2006US20060035876 Combination therapy of an SODm and a corticosteroid for prevention and/or treatment of inflammatory bone or joint disease
02/16/2006US20060035874 Pharmaceutical products and composition comprising specific anticholinergic agents, beta-2 agonists and corticosteroids
02/16/2006US20060035870 Carboxylic acid derivatives as IP antagonists
02/16/2006US20060035856 Purified polypeptides having IL-13 receptor activity
02/16/2006US20060035855 Purified polypeptides having IL-13 receptor activity
02/16/2006US20060035851 Use of hmgb1 in the treatment of tissue damage and or to promote tissue repair
02/16/2006US20060035809 Apoptosis-mimicking natural vesicles and use thereof in medical treatment
02/16/2006US20060035331 G-protein coupled receptors
02/16/2006US20060035315 Transporters and ion channels
02/16/2006US20060035293 Antibodies, polypeptides and polynucleotides, used for detection, prevention and treatment of diseases caused by gramnegative bacteria
02/16/2006US20060034933 Freeze-dried lecithin nanometer powder injection of ursolic acid and its preparation method
02/16/2006US20060034892 Composition for topical administration
02/16/2006US20060034801 Method for treating or preventing ischemia reperfusion injury or multi-organ failure
02/16/2006US20060034799 Tissue protective cytokines for the protection, restoration, and enhancement fo responsive cells, tissues and organs
02/16/2006CA2576949A1 Pyrazolo[1,5-a]pyrimidine derivatives
02/16/2006CA2576385A1 Novel formulation for l-tryptophane comprising carbidopa/benserazide
02/16/2006CA2576257A1 Anti-inflammatory agents
02/16/2006CA2576153A1 Use of n-desmethylclozapine to treat human neuropsychiatric disease
02/16/2006CA2575980A1 Combination of a selective noradrenaline reuptake inhibitor and a pdev inhibitor
02/16/2006CA2575014A1 Crp lowering agent
02/16/2006CA2574292A1 Piperazine derivatives with ccr3 inhibiting activity
02/16/2006CA2573066A1 Mercaptoimidazoles as ccr2 receptor antagonists
02/16/2006CA2572752A1 Pyrazole derivatives for treating conditions mediated by activation of the adenosine a2b or a3 receptor
02/16/2006CA2571143A1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
02/16/2006CA2570324A1 Rage fusion proteins and methods of use
02/15/2006EP1626048A1 Crystal of benzimidazole derivative and process for producing the same
02/15/2006EP1625854A1 Albumin conjugates containing a glucuronic linker
02/15/2006EP1625143A1 Estratriene derivatives
02/15/2006EP1625127A1 Azaindole compounds as kinase inhibitors
02/15/2006EP1487456B1 Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions
02/15/2006EP1482787A4 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
02/15/2006EP1154767B1 Substituted stilbene compounds with vascular damaging activity
02/15/2006CN1735618A New tricyclic derivatives as LTD4 antagonists
02/15/2006CN1735427A Pain relief agents
02/15/2006CN1735415A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
02/15/2006CN1735414A Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists
02/15/2006CN1735402A Polymer composition including large ring alkatriene compound
02/15/2006CN1733725A Process for preparing 2-iminopyrrolidine derivatives
02/15/2006CN1733285A Film-coated tablet for increasing bone force and process for preparing the same
02/15/2006CN1733269A Drop pill made from root rhizome and herb of common lamiophlomis and process for preparing the same
02/15/2006CN1733268A Heat clearing and detoxicating pill containing vomiting nut